Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00463996
Status:
UNKNOWN
Last Update Posted:
2007-04-20
First Post:
2007-04-18
Brief Title:
MRI in Staging Ovarian Cancer Using MRI Contrast Agent
Sponsor:
University of Aarhus
Organization:
University of Aarhus
Study Overview
Official Title:
Værdien af MRI Til Staging af cOvarii-et Prospektivt Studie
Status:
UNKNOWN
Status Verified Date:
2007-04
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Can MRI be used to stage ovarian cancer
Detailed Description:
Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound Studies have shown an increase in pos predictive value by adding contrast iv to the MR-examination protocol We compare staging of ovarian cancer by 1MRI without contrast standard method to 2MRI with contrast agent iv new methodin the same patient Golden standard are findings at operation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None